Market capitalization | $385.56m |
Enterprise Value | $378.54m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.67 |
P/S ratio (TTM) P/S ratio | 1.71 |
P/B ratio (TTM) P/B ratio | 1.00 |
Revenue growth (TTM) Revenue growth | -4.33% |
Revenue (TTM) Revenue | $226.11m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
10 Analysts have issued a CryoPort forecast:
10 Analysts have issued a CryoPort forecast:
Sep '24 |
+/-
%
|
||
Revenue | 226 226 |
4%
4%
|
|
Gross Profit | 78 78 |
10%
10%
|
|
EBITDA | -41 -41 |
78%
78%
|
EBIT (Operating Income) EBIT | -72 -72 |
45%
45%
|
Net Profit | -158 -158 |
240%
240%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Head office | United States |
CEO | Jerrell Shelton |
Employees | 1,170 |
Founded | 1990 |
Website | www.cryoport.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.